Navigation Links
ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO

MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 4, 2007 - ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announced today the presentation of data from its Quinamed(R) (amonafide dihydrochloride) phase 1/2a dose-escalation study, designed to identify a genotypically optimised dose of Quinamed in heavily pre-treated patients with a variety of solid tumors. The key outcomes from this study were (i) demonstration that dose level could be optimised according to patient genotype, (ii) the drug was well tolerated, with predictable and manageable side effects, and (iii) there was evidence of anticancer activity in several solid tumor types.

Dr. John Kuhn of the University of Texas Health Science Center in San Antonio, TX, along with the investigators at Sarah Cannon Cancer Center, TN and University of Louisville, KY discussed the data in an oral presentation at the American Association of Clinical Oncology (ASCO) 43rd Annual Meeting in Chicago, Illinois.

"The clinical activity of amonafide against a variety of cancers has long been recognized, but development has been hampered by the unpredictable side effect profile for patients" said Dr Kuhn. "We are excited by the new opportunities that personalized dosing of Quinamed offers for a range of solid tumor patients who have developed resistance to existing therapies."

Highlights of the presentation included:

-- Confirmation that genotyping of patients prior to treatment allows for optimized personalized dosing and improved drug tolerance.

-- Patients with rapid and intermediate acetylator genotypes (who more rapidly metabolize the drug to the acetylated derivative associated with side effects) achieved a maximum tolerated dose (MTD) of 320 mg/m2 of Quinamed weekly, whilst patients with slow acetylator genotypes achieved an MTD of 400 mg/m2 of Quinamed weekly (three weeks on treatment followed by one week off treatment,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
2. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
3. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
(Date:5/29/2015)... May 29, 2015  Excite Medical was established by ... the years, Excite Medical, under the leadership of ... company, with a solid track record of providing unparalleled ... and distributor base.  Photo - ... Medical has been possible, in large part, due to ...
(Date:5/29/2015)... NEW BRUNSWICK, N.J. , May 29, 2015 /PRNewswire-USNewswire/ ... biotech start-up companies originally funded with investments from Foundation ... their research at Bio International 2015 as part of ... the Conference, announced FVCG President James M. Golubieski ... event for the biotechnology industry, will be held in ...
(Date:5/29/2015)... Calif. , May 29, 2015  The annual ... 1-5 physicians ranks Praxis EMR as #1 across all ... Book Market Research LLC conducts a poll of EHR ... with the results.    Praxis EMR ... of the 18 performance based criteria used by Black ...
Breaking Medicine Technology:Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2
(Date:5/29/2015)... Los Angeles, CA (PRWEB) May 29, 2015 ... giant leap forward in Los Angeles thanks to the ... Mohebi. Dr. Mohebi has combined ARTAS hair ... the most advanced hair restoration procedures available anywhere. , ... process of directly and individually harvesting hair follicle grafts ...
(Date:5/29/2015)... CO (PRWEB) May 29, 2015 ... new addiction, substance abuse, and co-occurring mental health ... and ribbon cutting for the general public on ... 2nd. , The Recovery Village at Palmer Lake ... intensive outpatient programming, utilizing traditional and evidence-based therapies, ...
(Date:5/29/2015)... Red Hot & Blue Restaurants , ... & Blue restaurant at 525 New Waverly Place in Cary, ... “The Red Hot & Blue Restaurant was previously located in ... have moved to a new location in the center,” said ... all the activities on the Promenade–with outdoor seating and service, ...
(Date:5/29/2015)... San Diego, California (PRWEB) May 29, 2015 ... Common Core” and have joined the national effort to teach ... Many parents in the U.S. have been “sickened” by the ... country. However, love it or hate it, Common Core is ... the District of Columbia. Parents are now seeking ways ...
(Date:5/29/2015)... Mediaplanet has joined forces with Raw Elements ... importance of proper sun protection. The print component of ... circulation of approximately 250,000 copies and an estimated readership ... through a vast social media strategy, and across a ... explore the digital version of the campaign, click ...
Breaking Medicine News(10 mins):Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Doctors Discover a Cure for the Common Core 2
... ... the award-winning educational television program, “Insights” with Hugh Downs, as part of an upcoming ... ... Emerald Express International , a visionary company dedicated to bringing the highest-quality consumable ...
... ... 10-minute, Non-radioactive 13C-urea Breath Testing to the Western U.S. States. , ... Newfields, NH (PRWEB) ... diagnosis and monitoring of gastroenterological and liver related diseases, today announced it has ...
... ... of people between the ages of 35 to 44 have lost a tooth, ... the age of 74. With permanent tooth replacement treatments such as dental implants ... unique incentive for patients who don’t want the hassle of long waiting periods ...
... ... Initiated Studies Offers Expanded Features for Compliance and Effectiveness. , ... Charlottesville, VA, San Francisco, CA, New York, ... openQ has released an expanded offering for managing Investigator Initiated Studies/ Trials (IIS/IIT). ...
... ... Pioneer , ... May 26, 2010 -- Optovue, the company that launched the first FDA cleared Fourier/spectral ... over the same period in fiscal 2009., , ,“Following our 19% revenue growth in 2009 ...
... ... utilizes social media to spread the word. , ... Newcastle, Maine (Vocus) May 26, 2010 -- A new effort to gather ... Social Security Stories Project is seeking story submissions from the public, with a goal ...
Cached Medicine News:Health News:Emerald Express International to be Featured on ‘Insights' with Hugh Downs this Spring in a Segment that Spotlights Glutathione and Anti-Aging 2Health News:Emerald Express International to be Featured on ‘Insights' with Hugh Downs this Spring in a Segment that Spotlights Glutathione and Anti-Aging 3Health News:Exalenz Bioscience Expands Market Coverage for the BreathID Breath Test System 2Health News:Exalenz Bioscience Expands Market Coverage for the BreathID Breath Test System 3Health News:As Popularity of Dental Implants Rise, a Chicago Cosmetic Dentistry Practice's On-site Lab Offers Patients a Unique Incentive 2Health News:As Popularity of Dental Implants Rise, a Chicago Cosmetic Dentistry Practice's On-site Lab Offers Patients a Unique Incentive 3Health News:OpenQ Announces the Release of openIIS 2.5 2Health News:Optovue Q1 2010 Revenue Up 57% Over Same Quarter 2009 2Health News:New Project Gathers Stories about Social Security for Book, Awareness Effort 2Health News:New Project Gathers Stories about Social Security for Book, Awareness Effort 3
... oximeters available, Datex-Ohmeda s TuffSat is the ... transport, and EMS. TuffSat comes fully loaded ... index measurement) a quick, easy-to-use clinical ... perfusion at the sensor site. Now you ...
... clinical information. , ,S/5 Clinical Communications ... solutions that help you and your care ... You will have access to essential patient ... with your care team and specialists, independent ...
... safe and easy patient monitoring during MRI, ... special needs of the MRI environment. It allows ... MRI, promoting safety and flexibility., ,Though designed ... all the key benefits of the S/5 Monitoring ...
... and comprehensive solution for advanced arrhythmia ... (ARRWS) provides one compact, PC-based solution ... patients. It connects to Datex-Ohmeda Network ... up to 16 beds., ,The ...
Medicine Products: